The Patent Finder
US

Method of Treating Diseases

US 10,695,397 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Feb 3, 2036 · Medium confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Filed Dec 27, 2018 as application 16/233,749 · Granted Jun 30, 2020
Base term, 20 years from filing
Today
20 years from filing
2016 2036
Clock starts
Feb 3, 2016
Ends no later than
Feb 3, 2036
Granted
Jun 30, 2020
base term fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
9
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 3, 2016, when application 15/014,634, the earliest non-provisional in its chain, was filed (this one was filed Dec 27, 2018)Feb 3, 2036High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Feb 3, 2036Medium confidence

This family

US 10,238,709In force
Feb 2036
Feb 2036
US 10,695,397this patent
no later than Feb 2036
no later than Feb 2036
US 11,052,126In force
Feb 2036
Feb 2036
US 11,338,011In force
Feb 2036
Feb 2036
US 11,857,595In force
Feb 2036
Feb 2036
US 11,510,963In force
Feb 2036
Feb 2036
Application 18/514,644Abandoned
not computed
not computed
US 12,251,418In force
Feb 2036
Feb 2036
8 of 9 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 28, 2020
Reel 51645, frame 818
Mamluk, RoniChiasma, Inc.Assignment of Assignor's Interest
Jan 28, 2020
Reel 51645, frame 863
Teichman, Sam L.Chiasma, Inc.Assignment of Assignor's Interest
Apr 14, 2020
Reel 52394, frame 664
Chiasma, Inc.HCR Collateral Management, LLCSecurity Interest
Jan 24, 2022
Reel 58739, frame 949
Chiasma, Inc.Amryt Endo, Inc.Merger
Feb 18, 2022
Reel 59048, frame 944
Amryt Endo, Inc.Ares Capital Corporation, As Administrative AgentSecurity Interest
Mar 31, 2022
Reel 59463, frame 374
HCR Collateral Management, LLCAmryt Endo, Inc. (Formerly Chiasma, Inc.)Release of Security Interest
Apr 13, 2023
Reel 63318, frame 849
Ares Capital Corporation, As Administrative AgentAmryt Pharmaceuticals, Inc.; Amryt Endo, Inc.; Amryt Research Limited; Amryt Genetics LimitedRelease of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Pharmaceuticals, Inc.Release of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Endo, Inc.Release of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Research LimitedRelease of Security Interest
Apr 13, 2023
reel/frame not recorded
Ares Capital Corporation, As Administrative AgentAmryt Genetics LimitedRelease of Security Interest
Mar 19, 2024
Reel 66833, frame 786
McEvoy, JohnAmryt Endo, Inc.Change of Address
Jan 7, 2026
Reel 73389, frame 551
Amryt Endo, Inc.; Amyrt Pharmaceuticals Inc.Amryt Pharmaceuticals Inc.Merger and Change of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited